Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a ...

ADRs, foreign-traded stocks, OTC listings, and Canadian securities are not eligible for extra payments. First-time coverage ...